Swiss vote to ban GM crops deprives farmers of choice
EuropaBio, the EU association for bioindustries regrets the negative result for Switzerland, as a location for research and innovation. Although the ban only concerns the commercial cultivation of GM crops, from experience with the de facto moratorium in the European Union, the impact will be acutely felt in terms of investment in research and innovation. Field trials in the EU declined significantly during this period.
The ban means that Swiss farmers will be deprived of the choice to use advanced biotechnologies. The European Bioindustry will continue to campaign to offer farmers and consumers the choice to opt for GM technologies.
There is no scientific basis to the banning of GM technologies. This year marks 10 years of wide scale commercial planting of biotech crops and saw the one billionth acre of GM crops planted. Biotech crops were grown by approximately 8.25 million farmers in 17 countries in 2004. Notably, 90% of the beneficiary farmers were resource-poor farmers from developing countries.
A recent study by PG Economics and published in the peer reviewed journal AgBioForum reports that farmers using the technology increased their income by US$27 billion during the period 1996 to 2004 with significant, additional environmental benefits delivered.
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.